News
NORTH CHICAGO, IL, USA I July 30, 2025 I AbbVie (NYSE: ABBV) today announced positive topline results from the first of two pivotal studies of the Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback